Accepted at 7:25 p.m. Mar, 04, 2024 by thomas.holmes
Author: DillingerMed
Related Note: 1474686441354
Rationale for change

UW Step 1 QID 107624 says that Potter syndrome is incorrect terminology. Sequence is due to defects that develop sequentially while syndromes are multiple anomalies that develop independently.

Additional Resources Additional Resources
Text
ACE inhibitors and ARBs are contraindicated during {{c1::pregnancy}} due to possible {{c1::teratogenic}} effects
Extra
e.g., fetal renal malformations
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
FA2020 UPDATE: ACE inhibitors dilate the efferent arteriole, not constrict as the image below states:
Sketchy




Watch ACE Inhibitors, ARBs, Aliskiren
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo

Bootcamp
Watch associated Bootcamp video - RAAS Pharmacologic Targets

Watch associated Bootcamp video - Renal Pharmacology : ACEi, ARBs, Direct Renin Inhibitors

Watch associated Bootcamp video - Fetal Development : Teratogenic Medications
OME

One by one
Empty field
#AK_Step1_v12::#AMBOSS::ibaJtQ #AK_Step1_v12::#UWorld::Step::6443 #AK_Step1_v12::#Bootcamp::Reproduction::01_Fetal_Development::03_Teratogenic_Medications #AK_Step1_v12::#B&B::20_Repro::01_Embryology::05_Teratogens_I #AK_Step1_v12::^Systems::Renal::Pharmacology #AK_Step2_v12::#UWorld::Step::19122 #AK_Step1_v12::#FirstAid::14_Renal::05_Pharm::09_Angiotensin_II_Receptor_Blockers #AK_Step1_v12::^Systems::Cardio::Pharmacology #AK_Step1_v12::#Physeo::09_Pharm::06_Renal::06_ACE_inhibitors #AK_Step1_v12::#Bootcamp::Cardiology::10_Renin-Angiotensin-Aldosterone_System::02_Direct_Pharmacologic_Targets #AK_Step2_v12::!Shelf::FM::no_dupes #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#Pixorize::03_Pharmacology::18_Renal_Pharm::09_Angiotensin_II_Receptor_Blockers_(ARBs) #AK_Step1_v12::#AMBOSS::6xajx5 #AK_Step2_v12::!Shelf::ObGyn::no_dupes #AK_Step1_v12::#NBME::Free120 #AK_Step1_v12::#SketchyPharm::02_Cardio_&_Renal::01_Heart_Failure_Drugs::02_ACE_Inhibitors,_ARBs,_Aliskiren #AK_Step1_v12::#UWorld::Step::12262 #AK_Step1_v12::#UWorld::#UWSA1 #PANCE::EOR::IM #AK_Step1_v12::#Bootcamp::Nephrology::15_Renal_Pharmacology::06_ACEi,_ARBs,_Direct_Renin_Inhibitors #AK_Step2_v12::#B&B::02_Cardiology::06_Other_Topics::04_Hypertension #AK_Step2_v12::#OME::01_Medicine::01_Cardiology::09_Hypertension #AK_Step1_v12::#B&B::05_Cardio::08_Hypertension::03_Antihypertensives #AK_Step2_v12::#B&B::11_ObGyn::01_Obstetrics::05_Teratogens #AK_Step1_v12::#FirstAid::14_Renal::05_Pharm::08_Angiotensin-Converting_Enzyme_Inhibitors #AK_Step1_v12::#Physeo::09_Pharm::06_Renal::07_Angiotensin_II_Receptor_Blockers #AK_Step2_v12::#Resources_by_rotation::IM::ome::cardio::htn #AK_Step2_v12::#Resources_by_rotation::ObGyn::uw::dorian #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Cardiology::Hypertension #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#Resources_by_rotation::FM::ome::cardio::htn #AK_Step1_v12::#Pixorize::03_Pharmacology::18_Renal_Pharm::01_ACE_Inhibitors #PANCE::CARDIO::hypertension #AK_Step1_v12::$AnKingUpdates::$Errata::v12 #PANCE::EOR::Family_med #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Original_Decks::Step_1::Zanki_Pharmacology !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step2_v12::#AMBOSS::6xajx5 #AK_Step2_v12::#UWorld::COMLEX::104157 #AK_Step1_v12::#Bootcamp::Cardiology::26_Hypertension::06_Antihypertensives